Exercise during and after cancer: what the evidence says

General Health

Exercise during and after cancer: what the evidence says

Exercise during and after cancer: what the evidence says

Introduction

For a long time, the advice after a cancer diagnosis was to rest. It had an apparent logic: treatment is exhausting, the body is at war, and conserving energy seemed sensible.

Evidence accumulated over the last two decades has turned that idea around. Today the major guidelines — among them those of the American College of Sports Medicine and the American Cancer Society — recommend avoiding inactivity and maintaining physical activity during and after treatment, individually adapted. Not as a remedy, but as part of care.

This article summarizes what the evidence supports and what it doesn't. Nothing here replaces the guidance of your medical team, who know your diagnosis, your treatment and your situation.

Complete rest doesn't protect you: it deconditions you. And deconditioning carries its own cost during treatment.

What is reasonably well established

It reduces cancer-related fatigue. This is the most consistent finding, and the most counterintuitive. Cancer fatigue is different from ordinary tiredness: it doesn't improve with sleep. Multiple systematic reviews find that exercise reduces it more effectively than most of the pharmacological alternatives studied.

It preserves muscle mass and function. Several treatments — chemotherapy, corticosteroids, hormone therapies, immobility — promote muscle loss. Worse muscle status is associated with more treatment toxicity and poorer tolerance. Strength training counters part of that loss.

It improves quality of life, anxiety and mood. With small-to-moderate effect sizes, but consistent ones.

It maintains functional capacity for everyday life through months of treatment, which is what weighs most day to day.

It's safe when properly prescribed. Trials with supervised programs show low rates of adverse events.

What is less certain

There are observational studies associating greater physical activity with better survival in several cancer types, particularly breast and colon. The association is notable and biologically plausible. But these are observational data: on their own they don't prove exercise causes that improvement, because people able to exercise tend to be in better shape to begin with. Randomized trials with survival as the primary endpoint are underway, and their results will settle this point.

The mechanisms under study — effects on myokines, inflammation, insulin sensitivity, tumor perfusion or NK cell activity — are mostly preclinical or preliminary findings. Interesting, not yet conclusive.

Put plainly: exercise improves how you get through treatment; that it also extends life is likely but not yet established. And in no case is it a treatment for cancer.

What the guidelines recommend

As a general framework for people with cancer, always adapted to the individual case:

  • Aerobic activity: about 150 minutes a week at moderate intensity, or 75 at vigorous intensity where appropriate. Walking counts and is usually the best option.
  • Strength: two sessions a week covering the major muscle groups, with adjusted loads.
  • Mobility: gentle range-of-motion work, especially relevant after surgery.

With one principle above all others: something is far better than nothing. In bad weeks, ten minutes of walking is a legitimate and valuable goal.

How to self-regulate during treatment

Chemotherapy cycles create good days and bad days with fair regularity. A reasonable approach:

Use perceived effort, not the plan. On a 0 to 10 scale, moving around 3–5 on average days and not going past 6 without specific guidance is a practical criterion.

Learn your cycle pattern. Many people identify after two or three cycles which days are worst and schedule the harder work on the better ones.

Don't compensate. A missed day isn't recovered by doubling up the next.

Break it up. Three ten-minute walks are worth as much as one thirty-minute walk and are far more manageable.

Measure with function. How many minutes you can keep walking, how many times you can stand up from a chair. These are better indicators than weight, which fluctuates for many reasons during treatment.

Precautions that always need checking

These are situations where exercise needs adjustment or supervision, and where your medical team should decide:

  • Low blood counts. Significant anemia, low platelets — bleeding risk — or neutropenia — infection risk, with caution around gyms and pools.
  • Catheters and central lines. These determine which upper-body exercises are appropriate.
  • Bone metastases. These restrict impact, axial loading and certain movements because of fracture risk. They require specific programming.
  • Post-surgery. Timelines and ranges are set by the surgeon.
  • Lymphedema or lymphedema risk. Progressive, supervised strength training is no longer contraindicated — current evidence supports it — but slow progression and an initial assessment are advisable.
  • Cardiotoxicity. Some treatments affect the heart; a cardiology assessment may be needed.
  • Peripheral neuropathy. Common with certain drugs; it affects balance and favors stable options such as a stationary bike.
  • Intense nausea, fever, new pain, dizziness or shortness of breath. Reason to stop and check in.

Wherever possible, the ideal is a program supervised by professionals trained in exercise oncology. Many hospitals and patient associations offer these programs, often free of charge.

After treatment

Recovering physical capacity is usually slower than expected, and that slowness discourages a lot of people. It's normal: months of treatment leave a level of deconditioning that doesn't reverse in two weeks.

A reasonable progression: start below what you think you can do, increase by around 10 % a week, prioritize consistency over intensity, and bring strength back in early, since that's what helps most in regaining independence. Late effects — persistent fatigue, neuropathy, cardiac or hormonal changes — deserve follow-up and shape the program.

Final thought

The message the evidence supports is both modest and powerful: moving during and after cancer treatment helps you get through it with less fatigue, more muscle and better mood, and it's safe when adapted to your situation. It doesn't cure, it doesn't replace anything, and not every day allows the same thing. If you're in treatment, the conversation worth having at your next appointment is a simple one: ask what kind of activity is appropriate in your specific case and whether there's a supervised program you can access. Starting with a short walk, today, is within reason for most people.

Oops, something didn't go as expected. Your data is safe. Reload the page to keep building your habits.
Reload ×

Reconnecting…

The connection to the server was lost and is being restored automatically.

Could not reconnect

Check your internet connection and try again.